Results 51 to 60 of about 84,994 (214)
Transcatheter closure of Ventricular Septal defects in Malta : initial experience [PDF]
Ventricular septal defects (VSD) consist of deficiencies of the wall separating the two ventricles. VSDs are the commonest congenital cardiac defects. Small VSDs rarely require intervention, however, larger defects cause ventricular volume overload with ...
Aquilina, Oscar +6 more
core
Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment [PDF]
Most patients with severe tricuspid regurgitation lack treatment options because of prohibitive surgical risk. New transcatheter treatments under development and investigation might be able to address this unmet clinical need.
Jonathan Curio +6 more
core +1 more source
Potential Candidates for Transcatheter Tricuspid Valve Intervention After Transcatheter Aortic Valve Replacement: Predictors and Prognosis. [PDF]
OBJECTIVES The aims of this study were to document the prevalence of concomitant tricuspid regurgitation (TR) before and after transcatheter aortic valve replacement (TAVR), to quantify potential eligibility for transcatheter tricuspid valve ...
Heg, Dik +9 more
core +4 more sources
Transcatheter closure of symptomatic aortopulmonary window in an infant [PDF]
An aortopulmonary window is a rare congenital cardiac defect. In the majority of symptomatic neonates and infants, primary surgical repair is the treatment of choice.
Brockmeier, Konrad +4 more
core
The Next Revolution: Percutaneous Aortic Valve Replacement
Aortic valve replacement (AVR) is a treatment of choice for patients with symptomatic severe aortic stenosis (AS). However, a significant proportion of these patients do not undergo surgical AVR due to high-risk features.
Martin B. Leon, Eugenia Nikolsky
doaj +1 more source
Background: Intervention for tricuspid regurgitation (TR) tends to happen concurrently with and is addressed during mitral valve surgery. Isolated TR interventions, however, are not unusual and are becoming more common.
Faizus Sazzad +6 more
doaj +1 more source
AIMS We aimed to demonstrate the feasibility and investigate the safety of a novel, self-expanding trans-catheter heart valve in a selected patient population with severe aortic stenosis. METHODS AND RESULTS Between January and September 2013, a
Glökler, Steffen +6 more
core +1 more source
Predicting mortality after transcatheter aortic valve replacement external validation of the Transcatheter Valve Therapy registry model [PDF]
BACKGROUND: The Transcatheter Valve Therapy (TVT) registry model was recently developed to predict the risk of in-hospital mortality in patients undergoing transcatheter aortic valve replacement.
Oliver Muller +34 more
core +4 more sources
The development of transcatheter mitral valve replacement therapies requires accurate post-processing analysis tools to provide D-shaped mitral annulus dimensions from 3-dimensional (3D) data.
N. Mai Vo +4 more
doaj +1 more source
Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
After the success and worldwide adoption of transcatheter aortic valve replacement (TAVR), the percutaneous replacement of a diseased mitral valve (MV) rapidly became a target for investigators and industry. The rejuvenated enthusiasm of industry in this field is also corroborated by the fact that, in 2015, ≈2.5 billion dollars were invested in MV ...
Luca Testa +5 more
openaire +4 more sources

